US District Judge Denies Conagra’s Motion to Dismiss Short-Weighting Lawsuit

Why It Matters

The ruling keeps the consumer fraud claims alive, exposing Conagra to potential liability and reputational risk while highlighting regulatory scrutiny of seafood labeling practices.

Key Takeaways

• Judge denies dismissal; case moves forward
• Injunction request denied; packaging unchanged
• Class‑action certification still pending
• STTP filler linked to neurotoxin concerns
• Conagra sold brands for $55 M to High Liner

Pulse Analysis

The seafood industry has long grappled with short‑weighting, a practice where fillers like sodium tripolyphosphate (STTP) are added to increase product weight. Consumers in New York and Massachusetts allege that Conagra’s Mrs. Paul’s and Van de Kamp’s frozen fish lines were inflated with STTP, a chemical also used in industrial applications and flagged for potential neurotoxic effects. This lawsuit underscores growing consumer vigilance over label accuracy, especially claims of "100 percent Whole Fish," and raises questions about supply‑chain transparency in processed seafood.

Legal analysts note that Judge John J. Tharp Jr.’s decision to reject Conagra’s motion to dismiss preserves the plaintiffs’ right to pursue damages, though the court limited relief by denying an injunction that would have forced a packaging redesign. The next procedural hurdle is class‑action certification, which could expand the case nationwide and amplify exposure. For Conagra, the litigation arrives shortly after its $55 million (≈$52 million) divestiture of the two brands to High Liner Foods, a move intended to streamline its portfolio but now shadowed by potential liability that may affect the sale’s perceived value.

Beyond the immediate parties, the case signals heightened regulatory and consumer pressure on seafood processors to substantiate weight and ingredient claims. Industry observers anticipate tighter FDA oversight and possible state‑level actions targeting deceptive labeling. Companies may need to invest in more rigorous testing and transparent sourcing to rebuild trust. For investors, the outcome could influence valuation metrics for firms with similar product lines, as litigation risk becomes an increasingly material factor in the frozen seafood segment.